Compartir
Información de la revista
Número
Vol. 28. Núm. S1.Abstracts of the 2022 Annual Meeting of the ALEH
(marzo 2023)
Abstracts of the 2022 Annual Meeting of the ALEH (Asociación Latinoamericana para el Estudio del Hígado)
Ann Hepatol. 2023;28 Supl 1:100904
Acceso a texto completo
P1- HIGH VIRAL SUPPRESSION AND IMPROVED SAFETY PROFILE OF TENOFOVIR ALAFENAMIDE RELATIVE TO TENOFOVIR DISOPROXIL FUMARATE IN CHRONIC HEPATITIS B PATIENTS TREATED FOR 5 YEARS
Wai Kay Seto, Ting-Tsung Chang, Abhijit Chowdhry, Chi-Yi Chen, Mustafa Kemal Celen, Xiaoli Ma, Mang Ma, Ajay Duseja, ... Edward J. Gane
Ann Hepatol. 2023;28 Supl 1:100904.1
Acceso a texto completo
P-2 DE NOVO LIPOGENESIS MARKERS ARE INVOLVED IN METABOLIC ASSOCIATED FATTY LIVER DISEASE PROGRESSION IN BTBR OB/OB MICE
Lucas Opazo-Rios, Manuel Soto-Catalan, Iolanda Lázaro, Aleix Sala-Vila, Cristian Pérez-Gallardo, Fabian Segovia-Miranda, Juan Antonio Moreno, Jesús Egido, Sebastián Mas-Fontao
Ann Hepatol. 2023;28 Supl 1:100904.2
Acceso a texto completo
P-3 PLASMA EXCHANGE WITH ALBUMIN INCREASES EFFECTIVE ALBUMIN LEVELS IN PATIENTS WITH ACUTE-ON-CHRONIC LIVER FAILURE
Raquel Horrillo, Anna Mestre, Alba Pérez, Jordi Vidal, Estefania Alcaraz, Mireia Torres, Vicente Arroyo, Javier Fernández, ... Montserrat Costa
Ann Hepatol. 2023;28 Supl 1:100904.3
Acceso a texto completo
P-4 RISK OF HCC IN SOUTH AMERICANS ASSOCIATED WITH TLL1 VARIANT SINGLE NUCLEOTIDE POLYMORPHISM
Andre Boonstra, Domingo Balderramo, Dhamina Karim, Jhon Prieto Ortiz, Javier Diaz Ferrer, Angelo Mattos, Marcos Arrese Jimenez, Enrique Carrera Estupinan, ... Jose Debes
Ann Hepatol. 2023;28 Supl 1:100904.4
Acceso a texto completo
P-5 THREE-DIMENSIONAL SINGLE-CELL ATLAS OF LIVER TISSUE ARCHITECTURE
Dilan Martinez, Maldonado Valentina, Cristian Perez, Valeria Candia, Hernán Morales-Navarrete, Fabián Segovia-Miranda
Ann Hepatol. 2023;28 Supl 1:100904.5
Acceso a texto completo
P-6 PATTERNS OF ANTIBIOTIC RESISTANCE IN PATIENTS WITH CIRRHOSIS AND SPONTANEOUS BACTERIAL INFECTIONS: ANALYSES OF THE MULTICENTER STUDY FROM ARGENTINA AND URUGUAY
Sebastián Marciano, Maria Nelly Gutierrez Acevedo, Sabrina Barbero, Lorena del Carmen Notari, Marina Agozino, Jose Luis Fernandez, Maria Margarita Anders, Nadia Grigera, ... Adrian Gadano
Ann Hepatol. 2023;28 Supl 1:100904.6
Acceso a texto completo
P-7 LIVER INJURY AFTER COVID-19 VACCINATION COMPARED TO POST-INFLUENZA VACCINES: RETROSPECTIVE COHORT STUDY
Marlene Padilla Lopez, Natalia Sobenko, Valeria Ines Aliperti, Vanina Cecilia Stanek, Maria Florencia Grande Ratti, Fernando Ezequiel Jabif, Marcelo Gabriel Vallone, Alejandra Villamil
Ann Hepatol. 2023;28 Supl 1:100904.7
Acceso a texto completo
P-8 EXTRACELLULAR VESICLE-DERIVED MICRORNA SIGNATURE IN HCV AND HCV/HIV PATIENTS WITH DIFFERENT STAGES OF LIVER FIBROSIS
Victoria Cairoli, Daniel Valle Millares, Pablo Ryan, Lourdes Dominguez, Luz Martín-Carbonero, Beatriz Ameigeiras, Verónica Briz, Amanda Fernandez Rodriguez, ... Pamela Valva
Ann Hepatol. 2023;28 Supl 1:100904.8
Acceso a texto completo
P- 9 BIOMARKERS OF THE BACTERIAL, VIRAL AND HUMAN GUT TRANSCRIPTOME IN METABOLIC ASSOCIATED FATTY LIVER DISEASE (MAFLD) IN ARGENTINA
María Florencia Mascardi, Flavia Noelia Mazzini, Bárbara Suárez, Vera M. Ruda, Sebastián Marciano, Paola Casciato, Adrián Narvaez, Leila Haddad, ... Julieta Trinks
Ann Hepatol. 2023;28 Supl 1:100904.9
Acceso a texto completo
P-10 PATTERNS OF PROGRESSION AND TREATMENT DISCONTINUATION IN A REAL LIFE LATIN AMERICAN PROSPECTIVE COHORT STUDY OF INTERMEDIATE-ADVANCED HEPATOCELLULAR CARCINOMA: SECOND INTERIM ANALYSIS
Federico Piñero, Margarita Anders, Carla Bermudez, Ezequiel Demirdjian, Adriana Varón, Ana Palazzo, Jorge Rodriguez, Oscar Beltrán, ... Manuel Mendizabal
Ann Hepatol. 2023;28 Supl 1:100904.10
Acceso a texto completo
P- 11 PROTUMORIGENIC GALECTINS 1 AND 3 ARE UPREGULATED IN THE LIVER OF MICE EXPOSED TO CONTINUOUS GROWTH HORMONE LEVELS
Santiago De La Fuente, Verónica Gabriela Piazza, Nadia Sofía Cicconi, María Lorena Bacigalupo, Luciana Sarrias, Ana Isabel Sotelo, Andrzej Bartke, María Fernanda Troncoso, Johanna Gabriela Miquet
Ann Hepatol. 2023;28 Supl 1:100904.11
Acceso a texto completo
P- 12 PATHOGENIC VARIANT OF PNPLA3 DOES NOT ASSOCIATE WITH HEPATOCELLULAR CARCINOMA IN SOUTH AMERICANS. A REPORT FROM THE ESCALON NETWORK
Domingo Balderramo, Joshep Akambase, Jhon Prieto Ortiz, Javier Diaz Ferrer, Angelo Mattos, Marcos Arrese Jimenez, Enrique Carrera Estupinan, Zwier Groothuismink, ... Jose Debes
Ann Hepatol. 2023;28 Supl 1:100904.12
Acceso a texto completo
P-13 PREVALENCE, CHARACTERIZATION, AND SURVIVAL OF ACUTE ON CHRONIC LIVER FAILURE IN A LATIN AMERICAN COHORT: A MULTICENTER STUDY
Francisco Idalsoaga, Luis Antonio Díaz, Gustavo Ayares, Jorge Arnold, Víctor Meza, Franco Manzur, Joaquín Sotomayor, Hernán Rodríguez, ... Juan Pablo Arab
Ann Hepatol. 2023;28 Supl 1:100904.13
Acceso a texto completo
P-14 OPTIMIZATION OF MOLECULAR METHODS FOR SARS-CoV-2 QUALITATIVE DETECTION AND GENOTYPING IN RESPIRATORY SPECIMENS FROM PATIENTS WITH LIVER DISEASE
Vanessa Duarte da Costa, Alanna Calheiros Santos, Lucas Limas da Silva, Wilian Jean Wiggers, Claudia Alexandra Pontes Ivantes, Danielle Malta Lima, Jeová Keny Baima Colares, Deusilene Souza Vieira Dallacqua, ... Livia Melo Villar
Ann Hepatol. 2023;28 Supl 1:100904.14
Acceso a texto completo
P-15 MMP-2 AND MMP-9 LEVELS IN ALCOHOLIC LIVER DISEASE, NON-ALCOHOLIC FATTY LIVER DISEASE AND CHRONIC HEPATITIS C
María Lemus-Peña, Abigail Hernandez-Barragan, Daniel Montes de Oca-Ángeles, Marisela Hernandez-Santillan, Daniel Santana-Vargas, Moisés Martinez-Castillo, Zaira Medina-Avila, Aldo Torre-Delgadillo, ... Gabriela Gutiérrez-Reyes
Ann Hepatol. 2023;28 Supl 1:100904.15
Acceso a texto completo
P-16 FIRST MICRO ELIMINATION INTERVENTION OF HEPATITIS B &C IN INMATES OF THE EIGHT PRISONS IN THE PROVINCE OF MENDOZA, ARGENTINA
Gabriela Villar, Laura Rolla, Laila Hadid, Vanina Padovani, A Massutti, Diego Terraza, Hector Cuello, Roberto Perez Ravier, ... Carlos Espul
Ann Hepatol. 2023;28 Supl 1:100904.16
Acceso a texto completo
P- 17 FRAILTY AND COVERT HEPATIC ENCEPHALOPATHY IN CIRRHOTIC PATIENTS AT A THIRD LEVEL HOSPITAL IN GUATEMALA
Katherine Maldonado, Abel Sánchez
Ann Hepatol. 2023;28 Supl 1:100904.17
Acceso a texto completo
P- 18 TREATMENT WITH BEVACIZUMAB IN HIGH OUTPUT CARDIAC FAILURE DUE TO SEVERE HEPATIC COMPROMISE IN HEREDITARY HEMORRHAGIC TELANGIECTASIA PATIENTS: OBSERVATIONAL COHORT STUDY
Carolina Vazquez, Juan Bandi, Marcelo Serra
Ann Hepatol. 2023;28 Supl 1:100904.18
Acceso a texto completo
P-19 SPLENIC IRON OVERLOAD IN PATIENTS WITH HEREDITARY HEMOCHROMATOSIS
Maria Florencia Yamasato, Mariano Volpacchio, María Alejandra Avagnina, Enzo Rey, Alejandra Vellicce, Esteban Gonzalez Ballerga, Juan Antonio Sordá, Jorge Daruich
Ann Hepatol. 2023;28 Supl 1:100904.19
Acceso a texto completo
P- 21 DOCOSAHEXAENOIC ACID AND ITS DERIVATIVE MARESIN1 IMPROVE CHRONIC LIVER DAMAGE ASSOCIATED WITH THE PROMOTION OF APOPTOSIS PATHWAYS AND LIVER REGENERATION IN A SPRAGUE-DAWLEY MODEL.
Jessica Zúñiga-Hernández, Francisca Herrera Vielma, Matías Quiñones, María José Zúñiga
Ann Hepatol. 2023;28 Supl 1:100904.20
Acceso a texto completo
P-23 TEST AND TREAT: PROFILE OF PATIENTS DIAGNOSED WITH HEPATITIS C IN THE PRISON SYSTEM OF PORTO ALEGRE, BRAZIL
Eduardo Emerim, Viviane De Lima Cezar, Elenita Majaro Pinto Ferreira, Ana Francisca Perinazzo Fontoura, Daniel Conte Herter, Roslaine Ifran Amaral, João Nagildo, Rafael De Oliveira Nogueira, ... Pauline Soares Ferrugem
Ann Hepatol. 2023;28 Supl 1:100904.21
Acceso a texto completo
P- 24 RISK OF MULTIPLE DRUG INTERACTIONS POTENTIALLY LINKED TO SAFETY IN PATIENTS RECEIVING PANGENOTYPIC DIRECT-ACTING ANTIVIRALS FOR THE TREATMENT OF HEPATITIS C
Juan Turnes, Antonio García-Herola, Ramón Morillo, Marinela Méndez, Magdalena Rueda, Cándido Hernández, Antoni Sicras-Mainar, Jorge Mendez-Navarro
Ann Hepatol. 2023;28 Supl 1:100904.22
Acceso a texto completo
P- 25 ANTIOXIDANT EFFECT OF MORINGA OLEIFERA IN A MURINE MODEL OF NONALCOHOLIC STEATOHEPATITIS
Alejandra Monraz-Méndez, Raymundo Escutia-Gutiérrez, Jonathan Rodríguez-Sanabria, Ricardo De la Rosa-Bibiano, Laura Sánchez-Orozco, Arturo Santos, Juan Armendáriz-Borunda, Ana Sandoval-Rodríguez
Ann Hepatol. 2023;28 Supl 1:100904.23
Acceso a texto completo
P- 26 EFFECT OF PROTEIN X OF THE HEPATITIS B VIRUS AND HEXACHLOROBENZENE ON LIVER CELL GROWTH DYSREGULATION
Zahira Deza, Verónica Mathet, Lucia Coli, José Oubiña, Laura Alvarez, Ezequiel Ridruejo
Ann Hepatol. 2023;28 Supl 1:100904.24
Acceso a texto completo
P-27 CELLULAR EFFECTS OF IN VITRO LIPID OVERLOAD ON HEPATIC STELLATE CELLS AND HEPATOCYTES.
Adriana Campos-Espinosa, José Luis Pérez-Hernández, Gabriela Gutiérrez-Reyes, Carolina Guzmán
Ann Hepatol. 2023;28 Supl 1:100904.25
Acceso a texto completo
P- 28 ATORVASTATIN SHOWS ANTI-PROMOTOR AND ANTI-NEOANGIOGENIC EFFECT IN HEPATOCELLULAR CARCINOMA DEVELOPMENT IN VIVO AND IN VITRO MODEL BY INHIBITING TGF-β1/pERK SIGNALING PATHWAY
Ezequiel Ridruejo, Zahira Deza, Giselle Romero Caimi, Lucia Coli, AndLaura Alvarez
Ann Hepatol. 2023;28 Supl 1:100904.26
Acceso a texto completo
P-29 THE LIVER IN AMYLOIDOSIS: AN ANALYSIS OF THE INSTITUTIONAL AMYLOIDOSIS REGISTRY
María Adela Aguirre, Marcelina Carretero, Eugenia Villanueva, Elsa Mercedes Nucifora, María Soledad Saez, Erika Bárbara Brulc, Diego Pérez De Arenaza, Sebastián Marciano, ... María Lourdes Posadas Martínez
Ann Hepatol. 2023;28 Supl 1:100904.27
Acceso a texto completo
P- 30 CLINICAL FEATURES, TREATMENT, AND SURVIVAL OF PATIENTS WITH BUDD-CHIARI SYNDROME IN A HEPATOLOGY COLOMBIAN CENTER
Ximena Morales, Daniel Rojas, Felipe Durán-Torres, Carolina Salinas, Leonardo Pérez, Andrés Murillo, Enrique Ponce, Jorge Ceballos, ... Oscar Beltrán
Ann Hepatol. 2023;28 Supl 1:100904.28
Acceso a texto completo
P-31 SHORT-TERM EFFICACY AND SAFETY OF LOLA THERAPY IN PATIENTS WITH CIRRHOSIS AND MINIMAL HEPATIC ENCEPHALOPATHY: A REAL-LIFE COHORT STUDY
Fátima Higuera-De La Tijera, AB Moreno-Cobos, Christian Hinojosa-Segura, Diana Montemira-Orozco, Imran Cruz-Reyes, Juana Zavala-Ramírez, Daniel Santana-Vargas, Alfredo Servín-Caamaño, ... José Luis Pérez-Hernández
Ann Hepatol. 2023;28 Supl 1:100904.29
Acceso a texto completo
P- 32 HEPATITIS A AND E VIRUSES IN CÓRDOBA, ARGENTINA: WASTEWATER-BASED EPIDEMIOLOGY AS A SILENT SENTINEL OF THE TREND OF VIRUS CIRCULATION IN THE COMMUNITY
Anabella Fantilli, Guadalupe Di Cola, Paola Sicilia, Gonzalo Castro, María De Los Ángeles Marinzalda, Ariana Cachi, Gustavo Ibarra, Laura López, ... Viviana Ré
Ann Hepatol. 2023;28 Supl 1:100904.30
Acceso a texto completo
P-33 IMPACT OF SUSTAINED VIROLOGIC RESPONSE ON GLUCOSE PARAMETERS AMONG CHRONIC HEPATITIS C PATIENTS TREATED WITH DIRECT ACTING ANTIVIRALS
Hugo Cheinquer, Fabia Benetti, Alexandre de Araujo, Italo de Maman, Cristina Cheinquer Coelho Borges, Fernando Wolff Herz
Ann Hepatol. 2023;28 Supl 1:100904.31
Acceso a texto completo
P- 34 HEPATOCELLULAR CARCINOMA IN CHILE; A RETROSPECTIVE MULTICENTER STUDY OF 856 PATIENTS
Blanca Norero, Gonzalo Latorre, Diego Reyes, Carlos Benitez, Rodrigo Wolff, Marco Arrese, Macarena Viñuela Morales, Matias Torres Parada, ... Rodrigo Zapata
Ann Hepatol. 2023;28 Supl 1:100904.32
Acceso a texto completo
P- 35 RELINKAGE OF PATIENTS WITH CHRONIC HEPATITIS C INFECTION IN THE CONTEXT OF THE COVID-19 PANDEMIC
Gisela Fabiana Sotera, Melina Ferreiro, Margarita Martes, Cordero Nancy, Jonathan Salmon, Juan Sordá, Jorge Daruich, Esteban González Ballerga
Ann Hepatol. 2023;28 Supl 1:100904.33
Acceso a texto completo
P-36 RESULTS OF AN AUTOMATIC ALERT SYSTEM FROM MICROBIOLOGY TO LINK DIAGNOSIS TO TREATMENT IN PATIENTS WITH CHRONIC HEPATITIS C
Carlos Alventosa Mateu, María Dolores Ocete Mochón, Juan José Urquijo Ponce, Mercedes Latorre Sánchez, Inmaculada Castelló Miralles, Miguel García Deltoro, Enrique Ortega González, María José Bonet Igual, ... Moisés Diago Madrid
Ann Hepatol. 2023;28 Supl 1:100904.34
Acceso a texto completo
P-37 ASSESSMENT OF METABOLIC ASSOCIATED FATTY LIVER DISEASE, ALCOHOLIC LIVER DISEASE, AND DUAL DAMAGE IN APPARENTLY HEALTHY BLOOD BANK INDIVIDUALS
Jorge Emilio Lira-Vera, O Morales-Gutiérrez, Farid Yael Vargas-Durán, Pablo Alagón-Fernández Del Campo, Ana Karen Soto Martínez, Diana Montemira-Orozco, Andrés Burak-Leipuner, Christian Hinojosa-Segura, ... José Luis Pérez-Hernández
Ann Hepatol. 2023;28 Supl 1:100904.35
Acceso a texto completo
P-38 CRYPTOGENIC CHRONIC HEPATITIS: LOOKING FOR AN ETIOLOGICAL DIAGNOSIS
Guilherme Cançado Grossi Lopes, Aline Candolo Coelho Rocha, Jorge Nardelli Mateus, Patricia Zitelli Momoyo, Daniel Mazo Ferraz De Campos, Claudia Oliveira Pinto Marques De Souza, Marlone Cunha-Silva, Raquel Greca Dias, ... Mário Guimarães Pessôa
Ann Hepatol. 2023;28 Supl 1:100904.36
Acceso a texto completo
P- 39 CLINICAL SIGNIFICANCE OF GRADE 1 HEPATIC ENCEPHALOPATHY IN PATIENTS HOSPITALIZED FOR COMPLICATIONS OF CIRRHOSIS
Janaína Luz Narciso-Schiavon, Fernanda Cristina De Augustinho, Claudia Maccali, Esther Buzaglo Dantas-Correa, Leonardo Lucca Schiavon
Ann Hepatol. 2023;28 Supl 1:100904.37
Acceso a texto completo
P-40 IS THERE A DISTINCT PHENOTYPE OF NON-ALCOHOLIC FATTY LIVER DISEASE IN LEAN AND OVERWEIGHT PATIENTS?
Denise Siqueira Vanni, José Tadeu Stefano, Sebastião Mauro Bezerra Duarte, Patricia Momoyo Yoshiura Zitelli, Renato Gama Altikes, Karla Toda Oti, Mário Guimarães Pessoa, Flair José Carrilho, Claudia P Oliveira
Ann Hepatol. 2023;28 Supl 1:100904.38
Acceso a texto completo
P-41 SARCOPENIA AS A PREDICTOR OF RISK OF MINIMAL HEPATIC ENCEPHALOPATHY IN PATIENTS WITH LIVER CIRRHOSIS
Oscar Morales Gutiérrez, María de Fátima Higuera de la Tijera, José Luis Pérez Hernández
Ann Hepatol. 2023;28 Supl 1:100904.39
Acceso a texto completo
P-42 OBESITY AND ANTI-HBC IGG POSITIVITY INCREASE THE RISK OF HEPATOCELLULAR CARCINOMA IN A COHORT OF CHRONIC HEPATITIS C PATIENTS IN A TERTIARY OUTPATIENT CLINIC IN SÃO PAULO, BRAZIL
Alexandre Trazzi, Patricia Momoyo Zitelli, Daniel Mazo Ferraz, Roque Gabriel Rezende, Claudia Oliveira Pinto, Aline Chagas Lopes, Flair José Carrilho, Mário Guimarães Pessoa
Ann Hepatol. 2023;28 Supl 1:100904.40
Acceso a texto completo
P- 43 PIRFENIDONE PREVENTS NEOPLASTIC LESIONS DEVELOPMENT BY OXIDATIVE, FIBROGENIC, ANTIPROLIFERATIVE AND EPIGENETIC MECHANISMS REGULATION IN A MODEL OF CHEMICAL HEPATOCARCINOGENESIS
Hipólito Otoniel Miranda-Roblero, Hugo Christian Monroy-Ramírez, Marina Galicia-Moreno, Ana Sandoval-Rodriguez, Arturo Santos, Juan Armendáriz-Borunda
Ann Hepatol. 2023;28 Supl 1:100904.41
Acceso a texto completo
P- 44 HEPATOCELLULAR CARCINOMA IN CIRRHOTIC PATIENTS IN A PARAGUAYAN LIVER REFERENCE CENTER: CLINICAL AND EPIDEMIOLOGICAL CHARACTERISTICS
Lorena Martínez, Amaya Ortiz, Rodrigo Pérez, Mirian Colarte, Sebastián Díaz, Martin Sánchez, Johana Silvero, Maisa Vallejos, ... Jesus Ortiz
Ann Hepatol. 2023;28 Supl 1:100904.42
Acceso a texto completo
P- 45 ENDOSCOPIC ULTRASOUND SHEAR-WAVE ELASTOGRAPHY OF THE RIGHT AND LEFT HEPATIC LOBE PREDICTS LIVER CIRRHOSIS: A DIAGNOSTIC TRIAL
Carlos Robles-Medranda, Raquel Del Valle Zavala, Miguel Puga-Tejada, Martha Arévalo-Mora, Jorge Baquerizo-Burgos, Gabriela Egas-Izquierdo, Daniela Tabacelia, Roberto Oleas, ... Hannah Pitanga-Lukashok
Ann Hepatol. 2023;28 Supl 1:100904.43
Acceso a texto completo
P-48 EVALUATION OF IL-1β AND IL-1RA IN PATIENTS WITH CHRONIC LIVER DISEASES
Abigail Hernandez-Barragan, Z. Medina-Avila, D. Montes-de-Oca-Angeles, M. Lemus-Peña, M. Hernandez-Santillan, M. Martínez-Castillo, J.L. Pérez-Hernández, F. Higuera-De la Tijera, ... G. Gutiérrez-Reyes
Ann Hepatol. 2023;28 Supl 1:100904.44
Acceso a texto completo
P-49 CONCENTRATION OF IL-12 AND CXCL-10 IN CHRONIC LIVER DISEASES
Marisela Hernandez-Santillan, Moisés Martínez-Castillo, Zaira Medina-Ávila, Abigail Hernández-Barragan, María Lemus-Peña, Daniel Montes de Oca-Ángeles, José Luis Pérez-Hernández, Fátima Higuera-De la Tijera, ... Gabriela Gutiérrez-Reyes
Ann Hepatol. 2023;28 Supl 1:100904.45
Acceso a texto completo
P- 50 SEROPREVALENCE OF HEPATITIS E VIRUS IN HIV-INFECTED PATIENTS FROM ROSARIO, SANTA FE
Julián Acosta, Alceo Galimberti, Federico Marziali, Fernando Bessone, Alejandro Costaguta, Damián Águila, Sergio Lupo, Bruno Rocha De Lima, ... Ana Laura Cavatorta
Ann Hepatol. 2023;28 Supl 1:100904.46
Acceso a texto completo
P- 51 HEALTH EDUCATION AND SEROPREVALENCE OF HEV IN RURAL AND PERI-URBAN POPULATION, WITH AGRICULTURAL ACTIVITY IN BAHIA – BRAZIL - PRELIMINARY DATA
Fernanda Anjos Bastos, Uilza Miranda, Ramon Mendes Dos Santos, Caio Lopes Borges Andrade, Robert Schaer, Izabela Maria Del Rei Pereira Rosa, Maria Izabel Cerqueira Da Silva E Silva, Luiz Felipe Monteiro Darzé, ... Maria Isabel Schinoni
Ann Hepatol. 2023;28 Supl 1:100904.47
Acceso a texto completo
P-52 MALNUTRITION IN COMPENSATED AND DECOMPENSATED LIVER CIRRHOSIS
Andrea Curia, Maria Cielo Gutierrez, Cynthia Laura Musso, Jorge Daruich, Juan Antonio Sorda, Esteban Gonzalez Ballerga
Ann Hepatol. 2023;28 Supl 1:100904.48
Acceso a texto completo
P-53 HELICOBACTER PYLORI INFECTION IN PATIENTS WITH PEPTIC ULCER DISEASE AND CIRRHOSIS OF THE LIVER
Jaime Fustamante, Eduardo Monge, Claudia Soto, Julio Narroquin, Lucero Torres
Ann Hepatol. 2023;28 Supl 1:100904.49
Acceso a texto completo
P- 54 HEPATITIS C MICROELIMINATION IN FORMER DRUG USERS
Fernando Gruz, Maria Gimena Fernandez, Santiago Gimenez, Guillermo Dorado, Maria Laura Martin, Adrian Farias, Solange Mizrahi, Maricel Bellicoso
Ann Hepatol. 2023;28 Supl 1:100904.50
Acceso a texto completo
P 56- SHORT-TERM RESPONSE OF P300 EVOKED POTENTIAL IN PATIENTS WITH MINIMAL HEPATIC ENCEPHALOPATHY TREATED WITH L-ORNITHINE, L-ASPARTATE
José Luis Pérez-Hernández, Christian Hinojosa-Segura, Diana Montemira-Orozco, Andrés Burak-Leipuner, Juana Zavala-Ramírez, Imram Cruz-Reyes, María Escobedo-Silva, Fátima Higuera-de la Tijera, Daniel Santana-Vargas
Ann Hepatol. 2023;28 Supl 1:100904.51
Acceso a texto completo
P- 57 SURVIVAL AND LIVER TRANSPLANTATION FOR PATIENTS WITH ACUTE ON CHRONIC LIVER FAILURE IN URUGUAY
Martín Elizondo, Romina Rey, Victoria Mainardi, María Clara Gouarnalusse, Marcelo Valverde, Solange Gerona
Ann Hepatol. 2023;28 Supl 1:100904.52
Acceso a texto completo
P-58 PREVALENCE OF CHRONIC VIRAL HEPATITIS TYPE C IN PEOPLE DEPRIVED OF THEIR LIBERTY IN THE CERESOS OF THE STATE OF VERACRUZ, MEXICO: TOWARDS MICRO-ELIMINATION
María Teresa Guzmán Terrones, Ignacio Manuel Pérez Acosta, Mauricio Alfaro Centeno
Ann Hepatol. 2023;28 Supl 1:100904.53
Acceso a texto completo
P-60 DETERMINATION OF THE PREVALENCE OF HEPATITIS C VIRUS USING THE RAPID MONTEBIO HCV TEST IN A HIGH-RISK POPULATION OF HOSPITAL DEL SALVADOR, CHILE.
Alejandro Carvajal, Carlos Valdebenito, Luis Salazar, Gonzalo Veloso, Stephany Albán, Gabriel Mezzano
Ann Hepatol. 2023;28 Supl 1:100904.54
Acceso a texto completo
P-61 PREVALENCE OF HEPATITIS E VIRUS INFECTION ON CIRRHOTIC PATIENT POPULATION FROM ROSARIO
Julián Acosta, Alceo Galimberti, Federico Marziali, Fernando Bessone, Alejandro Costaguta, Hugo Tanno, Virginia Reggiardo, Daniela Gardiol, Ana Laura Cavatorta
Ann Hepatol. 2023;28 Supl 1:100904.55
Acceso a texto completo
P- 62 PREDICTION OF FIBROSIS PROGRESSION AND CLINICAL OUTCOMES WITH NON INVASIVE TESTS IN 10 YEARS FOLLOW UP OF PATIENTS WITH NON ALCOHOLIC STEATOHEPATITIS
Renato Gama Altikes, Patricia Momoyo Yoshiura Zitelli, Rosa Maria Nascimento Marcusso, Denise Vanni, José Tadeu Stefano, Flair J Carrilho, Mário Guimaraes Pessoa, Claudia P Oliveira
Ann Hepatol. 2023;28 Supl 1:100904.56
Acceso a texto completo
P- 63 TREATING HEPATITIS C (HCV) IN ADDICTION CENTERS IN OUR COMMUNITY: ANOTHER STEP TOWARDS MICROELIMINATION
Sonia Blanco-Sampascual, Rodrigo Oraa, Amaia Castrillo-Olabarria, Fernando Menendez-Blazquez
Ann Hepatol. 2023;28 Supl 1:100904.57
Acceso a texto completo
P- 64 HEPATITIS C VIRUS MICRO-ELIMINATION PROGRAM IN AN OPEN POPULATION
Edgar Rodríguez-, Fuentes, Fátima Higuera-De La Tijera, María Luisa Hernández-Medel, José Luis Pérez-Hernández, Raúl Serrano-Loyola, Guadalupe Guerrero-Avendaño
Ann Hepatol. 2023;28 Supl 1:100904.58
Acceso a texto completo
P-65 NOREPINEPHRINE INFUSION AS AN ALTERNATIVE TO ALBUMIN POST LARGE VOLUMEN PARACENTESIS IN CIRRHOTIC PATIENTS
Ernaldo Morales-Mairena, Fátima Higuera-De La Tijera, Andrea Enríquez-Constantino, Daniel Santana Vargas, José LuisPérez-Hernández
Ann Hepatol. 2023;28 Supl 1:100904.59
Acceso a texto completo
P-66 CARDIOVASCULAR RISK PROFILE AND ATHEROSCLEROSIS IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE
Maria Eduarda de Almeida Oliveira, Sérgio Augusto Antônio, Davi Cassiano Costa, Raphael Carreiro Moura, Daniele Araújo de Azeredo Coutinho, Carlos Roberto de Andrade Junior, Maria Auxiliadora Saad, Priscila Pollo Flores, Débora Vieira Soares
Ann Hepatol. 2023;28 Supl 1:100904.60
Acceso a texto completo
P-67 USEFULNESS OF 3 DIFFERENT POINTS OF THE LIVER TO EVALUATE FIBROSIS BY TRANSITIONAL ELASTOGRAPHY
Ernaldo Morales Mairena, Fátima Higuera-de-la Tijera, Daniel Santana Vargas, Erika Bojorges Valdez, Andrés Burak Leipuner, J García Espinosa, Felix García Juárez, José Luis Pérez-Hernández
Ann Hepatol. 2023;28 Supl 1:100904.61
Acceso a texto completo
P- 69 CHRONIC HEPATITIS B: EPIDEMIOLOGICAL CHARACTERISTICS, EVOLUTION AND PREVALENT PHASES, IN REFERENCE CENTERS IN PARAGUAY
Mirian Colarte, Marcos Girala, Lorena Martinez, Sebastian Diaz, Jesús Ortiz
Ann Hepatol. 2023;28 Supl 1:100904.62
Acceso a texto completo
P-70 HEPATITIS B IMMUNITY AMONG CHRONIC RENAL DISEASE UNDER HEMODIALYSIS
Alanna Calheiros Santos, Juliana Gil Melgaço, Lucas Lima da Silva, Vanessa Duarte da Costa, Juliana Custódio Miguel, Elisangela Ferreira da Silva, Julia Trece Marques, Giselle Prado do Nascimento, ... Livia Melo Villar
Ann Hepatol. 2023;28 Supl 1:100904.63
Acceso a texto completo
P- 71 BACTERIAL INFECTIONS IN CIRRHOTIC PATIENTS: ARE WE FACING AN EPIDEMIOLOGICAL CHANGE?
Bulaty Sofía, Jaureguizahar Fernanda, Zitelli Ludmila, Tamagnone Norberto, Navas Lisandro, Rifrani Gabriel, Ahumada Natalia, Cortese María Mercedes, ... Bessone Fernando
Ann Hepatol. 2023;28 Supl 1:100904.64
Acceso a texto completo
P- 73 ULTRASOUND VISUALIZATION OF THE LIVER
Ezequiel Demirdjian, Diego Arufe, Mariana Moreyra, Guillermo Troiani, Analia Cellerino, Diego Costa, Maria Pia Raffa
Ann Hepatol. 2023;28 Supl 1:100904.65
Acceso a texto completo
P- 75 COMPARISON OF EUS-GUIDED COIL PLUS CYANOACRYLATE VS CONVENTIONAL CYANOACRYLATE TECHNIQUE IN THE MANAGEMENT OF ACUTE GASTRIC VARICEAL BLEEDING. WHICH ONE IS BETTER?
Aldo Carvajal, Jorge Vargas, Ana Madrigal, Carolina Gutierrez, Manfred Aguilar, Marlon Rojas, Luis Arguedas, Pablo Cortes, ... Francisco Hevia
Ann Hepatol. 2023;28 Supl 1:100904.66
Acceso a texto completo
P- 76 ELEVATED FIBROSIS LEVEL IN PATIENTS COINFECTED WITH HEPATITIS AND COVID-19 DURING A LONGITUDINAL STUDY
Lucas Lima Da Silva, Vanessa Duarte Da Costa, Alanna Calheiros Santos, Juliana Custódio Miguel, Luciana Texeira De Barros E Vasconcellos, Wilian Jeans Wiggers, Claudia Alexandra Pontes Ivantes, Priscila Pollo-Flores, ... Livia Melo Villar
Ann Hepatol. 2023;28 Supl 1:100904.67
Acceso a texto completo
P- 77 EPIGENOME OF PATIENTS WITH LIVER FIBROSIS, WITH SUSTAINED VIRAL RESPONSE TO HCV IN LIVER BIOPSY AND LIQUID BIOPSY REVEALS THE ASSOCIATION OF DNA METHYLATION AND miRNA EXPRESSION WITH THE DEGREE OF SEVERITY
Ricardo De la Rosa-Bibiano, Rebeca Escutia-Gutiérrez, Eira Cerda-Reyes, Juan Manuel Aguilar, Ana Soledad Sandoval-Rodríguez, Juan Armendáriz-Borunda
Ann Hepatol. 2023;28 Supl 1:100904.68
Acceso a texto completo
P- 78 DIETHYlNITROSAMINE AND 2-ACETYLAMINOFLUORENE CHRONIC ADMINISTRATION LEADS TO BIOCHEMICAL, HISTOLOGIC AND GENETIC CHANGES RELATED TO HEPATOCELLULAR CARCINOMA IN WISTAR RATS
Jaime Sánchez-Meza, Marina Campos-Valdez, José Alfredo Domínguez-Rosales, Saraí Citlalic Rodríguez-Reyes, Erika Martínez-López, Juliana Marisol Godínez-Rubí, Adriana María Salazar-Montes, Laura Verónica Sánchez-Orozco
Ann Hepatol. 2023;28 Supl 1:100904.69
Acceso a texto completo
P- 79 LIVER TRANSPLANTATION FOR HEPATOCELLULAR, LOOKING FOR THE BETTER SELECTION CRITERIA. RESULTS FROM THE URUGUAYAN LIVER TRANSPLANT PROGRAM
Cinthya Coronado, Josemaría Menéndez, Alejo Gestal, Victoria Mainardi, Solange Gerona
Ann Hepatol. 2023;28 Supl 1:100904.70
Acceso a texto completo
P- 80 DIFFERENTIAL EXPRESSION OF MATRIX METALLOPROTEINASE 7 IN CHRONIC LIVER DISEASES
Daniel Montes de Oca-Angeles, M. Lemus-Peña, A. Hernandez-Barragan, M. Hernández-Santillán, Moisés Martinez-Castillo, Z. Medina-Avila, D. Santana-Vargas, A. Torre-Delgadillo, ... G. Gutiérrez-Reyes
Ann Hepatol. 2023;28 Supl 1:100904.71
Acceso a texto completo
P- 81 PREVALENCE OF HEV INFECTION IN HIV CARRIERS, PATIENTS WITH INFLAMMATORY BOWEL DISEASE AND CIRRHOTIC PATIENTS
Luan Henrique Paim Santos, Luíza Araújo de Santana Cavalcanti, Daniela Santana Mendes, Victoria Cruz Paraná, Júlia Stifelman Freire Alves, Fernanda Souza Novais, Sidelcina Rugieri Pacheco, Maria Alice Sant'Anna Zarife, ... Luciano Kalabric Silva
Ann Hepatol. 2023;28 Supl 1:100904.72
Acceso a texto completo
P- 82 VERY HIGH PREVALENCE OF STEATOSIS AND STRIKINGLY ELEVATED ANTIE VIRUS ANTIBODIES: RESULTS OF A LIVER DISEASE SCREENING CAMPAIGN
Alceo Galimberti, Victoria Trevizan, Sofia Bulaty, Fernanda Jaureguizahar, Antonela Ferrari, Ludmila Zitelli, Norberto Tamagnone, Juan Maurino, ... Fernando Bessone
Ann Hepatol. 2023;28 Supl 1:100904.73
Acceso a texto completo
P- 84 ENDOSCOPIC ULTRASOUND GUIDED LIVER BIOPSY, IS IT READY FOR PRIMETIME?
Daniela Hernández-Castro, Wagner Ramírez-Quesada, Carolina Gutiérrez-Ramírez, Sylvia Álvarez-Umaña, José Pablo Cortes-Navarrete, Aldo Carvajal-González, Francisco Hevia-Urrutia, Ana Lorena Madrigal-Méndez, Jorge Vargas-Madrigal
Ann Hepatol. 2023;28 Supl 1:100904.74
Acceso a texto completo
P- 85 HIGHER LEVELS OF ALKALINE PHOSPHATASIS AFTER 6-MONTH TREATMENT WITH URSODEOXYCHOLIC ACID WERE ASSOCIATED WITH EVOLUTION TO ORTHOTOPIC LIVER TRANSPLANTATION IN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS AND INFLAMMATORY BOWEL DISEASE
Diogo Delgado Dotta, Marcus Vinicius De Acevedo Garcia Gomes, Ana Elisa Rabe Caon, Davi Viana Ramos, Luisa Leite Barros, Débora Raquel Benedita Terrabuio, Eduardo Luiz Rachid Cançado
Ann Hepatol. 2023;28 Supl 1:100904.75
Acceso a texto completo
P- 89 CHARACTERISTICS AND SURVIVAL OF PATIENTS WITH LIVER CIRRHOSIS AT A REFERRAL CENTER IN PARAGUAY
Elías Morán, Marcos Girala, Guillermo Fernández, Adriana Medina, Jesús Ortiz Villalba
Ann Hepatol. 2023;28 Supl 1:100904.76
Acceso a texto completo
P- 90 EFFECT OF THE DELIVERY OF WRITTEN INFORMATION ON DISEASE-RELATED KNOWLEDGE IN PATIENTS WITH CIRRHOSIS AND ASSOCIATED FACTORS
Daniela Simian, Rosario Pino, Camila Vera, Emerson Rioseco, Camila Campos, Axel Polanco, Máximo Cattaneo, Juan Pablo Roblero, ... Jaime Poniachik
Ann Hepatol. 2023;28 Supl 1:100904.77
Acceso a texto completo
P- 91 CHANGES IN EARLY VISUAL PERCEPTION IN PATIENTS WITH MINIMAL HEPATIC ENCEPHALOPATHY
José Luis Pérez Hernández, Diana Montemira Orozco, Christian Israel Hinojosa-Segura, Julieta Zavala Ramírez, Imran Gibran Cruz Reyes, Maria Escobedo Silva, Fatima Higuera-de la Tijera, Daniel Santana Vargas
Ann Hepatol. 2023;28 Supl 1:100904.78
Acceso a texto completo
P- 93 INTERVENTIONS AND CLINICAL OUTCOMES IN PATIENTS EXCLUDED FROM PRE-LIVER TRANSPLANT EVALUATION IN A SINGLE CENTER EXPERIENCE
Alejandra Amaya, Margarita Gutiérrez, Martín Garzón, Fabiola Villalba, Yanet Mendez, Oscar Beltran, Geovanny Hernández, Carolina Salinas, ... Varón Adriana
Ann Hepatol. 2023;28 Supl 1:100904.79
Acceso a texto completo
P- 97 CHARACTERIZATION OF PATIENTS INFECTED WITH HEPATITIS C IN 2 REFERENCE CENTERS IN PARAGUAY, FROM APRIL 2000 TO SEPTEMBER 2021
José Mongelos, Marcos Girala, Sebastian Diaz, Sara Melgarejo, Jesus Ortiz
Ann Hepatol. 2023;28 Supl 1:100904.80
Acceso a texto completo
P- 99 ASSOCIATION OF LIVER ABNORMALITIES WITH DISEASE SEVERITY IN COVID-19
Jhankarla Hinojosa, Caio Magrini, Perla Schulz, Andrea Vieira, Roberto da Silva Junior
Ann Hepatol. 2023;28 Supl 1:100904.81
Acceso a texto completo
P- 101 TREATMENT OF PATIENTS INFECTED WITH HEPATITIS C VIRUS IN TWO REFERENCE CENTERS IN PARAGUAY.
José Mongelós, Marcos Girala, Mariam Garayo, Sara Melgarejo, Sergio Morinigo, Jesús Ortiz Villalba
Ann Hepatol. 2023;28 Supl 1:100904.82
Acceso a texto completo
P- 102 CLINICAL CHARACTERISTICS OF LIVER CIRRHOSIS SECONDARY TO METABOLIC SYNDROME AND COMPARISON WITH ETHYL CIRRHOSIS
Laura Martínez, Elias Morán, Marcos Girala
Ann Hepatol. 2023;28 Supl 1:100904.83
Acceso a texto completo
P- 103 PREVALENCE OF SARCOPENIA IN CIRRHOTIC PATIENTS IN AN OUTPATIENT SERVICE IN BRAZIL
Carolina Pretti Tumang de Andrade, Lara Ferrari Dalcumune, Nubia Mesquita Fiorese, Livia Zardo Trindade, Felipe Bertollo Ferreira, Mariana Poltronieri Pacheco
Ann Hepatol. 2023;28 Supl 1:100904.84
Acceso a texto completo
P- 104 EXPERIENCE AND CARDIOVASCULAR OUTCOMES IN POST-LIVER TRANSPLANT PATIENTS AT A REFERENCE TRANSPLANT CENTER IN COLOMBIA
Carlos Martinez, Catalina Gutierrez, Daniel Rojas, Sandra Saummet, Camila Galindo, Rafael Conde, Adriana Varon
Ann Hepatol. 2023;28 Supl 1:100904.85
Acceso a texto completo
P- 105 DETECTION OF HEPATITIS D VIRUS IN PATIENTS WITH CHRONIC HEPATITIS B FROM SOUTH AMERICA.
María Belén Pisano, Viviana E. Ré, Enrique Carrera, Domingo Balderramo, Jhon Prieto, Javier Díaz-Ferrer, Marco Arrese, Angelo Z. Mattos, ... Andre Boonstra
Ann Hepatol. 2023;28 Supl 1:100904.86
Acceso a texto completo
P- 107 EPIDEMIOLOGY, CLINICAL AND TISSUE CHARACTERISTICS OF A LARGE COHORT OF NAFLD/NASH FROM SOUTH AMERICA
Jhon Prieto Ortiz, Joseph Akambase, Angelo Mattos, Enrique Carrera Estupinan, Javier Diaz Ferrer, Andre Curia, Patricia Gallardo, Esteban Gonzalez Ballerga, ... Jose Debes
Ann Hepatol. 2023;28 Supl 1:100904.87
Acceso a texto completo
P- 108 POLYMORPHISMS OF HLA (LOCI DR 4*) IN HISPANICS AS RISK FACTOR FOR DE-NOVO AUTOIMMUNE HEPATITIS AFTER LIVER TRANSPLANTATION
Adriana Varón, Luisa Santos, Oscar Beltrán, Martin Garzón, Geovanny Hernandez, Carolina Salinas, Maria C. Torres, Andres Murcia, ... Gilberto Mejia
Ann Hepatol. 2023;28 Supl 1:100904.88
Acceso a texto completo
P- 109 NON-INVASIVE ASSESSMENT OF FIBROSIS REGRESSION IN VIROLOGICAL RESPONDERS SUSTAINED BY HEPATITIS C VIRUS
Dania Anaberta Campos García, Sánchez Abel
Ann Hepatol. 2023;28 Supl 1:100904.89
Acceso a texto completo
P-110 BIOPSY IN FOCAL LIVER LESIONS: CORRELATION FROM CLINICAL TO HISTOPATHOLOGY
Enrique Carrera, Freddy Holguin, Gabriela Quingalombo, Estibalys Zambrano, Silvia Lozada
Ann Hepatol. 2023;28 Supl 1:100904.90
Acceso a texto completo
P- 111 MORTALITY ON LIVER TRANSPLANT WAITING LIST: ANALYSIS OF A TRANSPLANT CENTER IN COLOMBIA
Cristina Torres, Andres Murcia, Diana Benavides, Oscar Beltran, Martin Garzon, Carolina Salinas, Geovanny Hernandez, Gilberto Mejia, ... Adriana Varon
Ann Hepatol. 2023;28 Supl 1:100904.91
Acceso a texto completo
P- 112 METABOLIC FATTY LIVER DISEASE: FIBROSIS AND SARCOPENIA FREQUENCIES AND CORRELATION
Helen Cristine Saldanha Ferreira, Hévila de Farias Passos, Rafaela Cunha da Silva, Larissa Carvalho Pereira, Juliana Pereira da Silveira dos Santos, Patrick Machado Cibin, Vinicius Costa Viana, Gabriela Landier, ... Priscila Pollo Flores
Ann Hepatol. 2023;28 Supl 1:100904.92
Acceso a texto completo
P- 113 TREATMENT OF CHRONIC HEPATITIS B IN TWO REFERENCE CENTERS IN PARAGUAY.
Mirian Colarte, Marcos Girala, Lorena Martínez, Sebastián Diaz, Jesús Ortiz
Ann Hepatol. 2023;28 Supl 1:100904.93
Acceso a texto completo
P-114 APPLICATION OF THE DONOR RISK INDEX IN LIVER TRANSPLANTATION IN THE MAIN TRANSPLANT CENTER IN PERU
P.Martin Padilla-Machaca, Omar Mantilla, José Rivera, Alfonso Solar, Bertha Cárdenas, Carmen Cerrón, Saul Espinoza, Wilmer Bacilio, ... Carlos Rondón
Ann Hepatol. 2023;28 Supl 1:100904.94
Acceso a texto completo
P-115 SUSCEPTIBILITY TO LIVER DAMAGE IN WOMEN DUE TO RISKY ALCOHOL CONSUMPTION.
José Luis Pérez-Hernández, Ernaldo Morales-Mairena, Andrea Enríquez-Constantino, Daniel Angel Santana Vargas, Fátima Higuera-de la Tijera
Ann Hepatol. 2023;28 Supl 1:100904.95
Acceso a texto completo
P-116 AUTOIMMUNE DISEASES ASSOCIATED WITH AUTOIMMUNE HEPATITIS: EXPERIENCE IN TWO PARAGUAYAN CENTERS.
Florencia Otazú, Marcos Girala, Pedro Mercado, Guillermo Fernández, Jesús Ortiz Villalba
Ann Hepatol. 2023;28 Supl 1:100904.96
Acceso a texto completo
P-117 HEPATOBILIARY INJURIES: EXPERIENCE OF THE MULTIDISCIPLINARY COMMITTEE AT THE HOSPITAL DE ESPECIALIDADES EUGENIO ESPEJO (HEE) IN QUITO – ECUADOR
Estibalys Zambrano, Silvia Lozada, Freddy Holguín, Gabriela Quingalombo, Enrique Carrera
Ann Hepatol. 2023;28 Supl 1:100904.97
Acceso a texto completo
P-118 HEPATOCELLULAR CARCINOMA. AN EXPERIENCE IN A TRANSPLANT CENTER IN COLOMBIA
Adriana Varón, José Leonardo Pérez, Cristina Torres, Juan Manuel Pérez, José Gabriel Caviedes, Diego Piñeros, Gilberto Mejía, Jairo Rivera, ... Oscar Beltrán
Ann Hepatol. 2023;28 Supl 1:100904.98
Acceso a texto completo
P-119 LIVER TRANSPLANTATION IN ACUTE ON CHRONIC LIVER FAILURE (ACLF): RESULTS OF THE MAIN TRANSPLANT CENTER OF PERU
Carmen Ana Cerron Cabezas, Rosa Luz Lopez Martinez, Gino Salcedo Bermudez, Pedro Martin Padilla Machaca, Bertha Eliana Cardenas Ramirez, Wilmer Bacilio Calderon, Omar Mantilla Cruzatti, Jose Rivera Romani, ... Carlos Felix Rondon Leyva
Ann Hepatol. 2023;28 Supl 1:100904.99
Acceso a texto completo
P-120 ANTHROPOMETRIC AND METABOLIC PROFILE IN NON-ALCOHOLIC FATTY LIVER DISEASE
Lara Ramos de Prado, Mariana Sophia Santos Almeida, Ana Ester Amorim de Paula, Maria Auxiliadora Nogueira Saad, Rosa Leonora Salerno Soares, Priscila Pollo Flores, Débora Vieira Soares
Ann Hepatol. 2023;28 Supl 1:100904.100
Acceso a texto completo
P-121 CORRELATION BETWEEN HEPATOPULMONARY SYNDROME AND OXYGEN SATURATION PULSE OXIMETRY IN CIRRHOTIC PATIENTS
Dayana Christo, Verônica Nicoli, Perla Schulz, Andrea Vieira, Roberto da Silva Junior
Ann Hepatol. 2023;28 Supl 1:100904.101
Acceso a texto completo
P-122 MAFLD PREVALENCE AND FACTORS ASSOCIATED WITH LIVER STEATOSIS IN PATIENTS WITH TRAUMATIC SPINAL CORD INJURY
Fernanda Barros Viana Coelho, Luiz Carlos Cassemiro, Sandro Barbosa De Oliveira, José Tadeu Stefano, Claudia Pinto Marques Souza De Oliveira
Ann Hepatol. 2023;28 Supl 1:100904.102
Acceso a texto completo
P-123 HEPATOCELLULAR CARCINOMA SURVIVAL: EXPERIENCE OF THE MULTIDISCIPLINARY COMMITTEE AT HOSPITAL ESPECIALIDADES EUGENIO ESPEJO IN QUITO – ECUADOR
Enrique Carrera, Jaysoom Abarca, German Abbdo, Cintya Borja, Wendy Calderon, Gabriela Camacho, Ximena Cuenca, Freddy Holguin, ... Estibalys Zambrano
Ann Hepatol. 2023;28 Supl 1:100904.103
Acceso a texto completo
P-124 TITLE: CLINICAL CHARACTERISTICS OF CIRRHOTIC PATIENTS WITH VARICEAL BLEEDING IN A SINGLE CENTER EXPERIENCE. DESCRIPTIVE STUDY
Martin Garzon, Maria Lucia Bernal, David Ramirez, Geovanny Hernandez, Carolina Salinas, Jorge Ceballos, Enrique Ponce, Cristina Torres, ... Oscar Beltran
Ann Hepatol. 2023;28 Supl 1:100904.104
Acceso a texto completo
P-126 PREVALENCE OF LIVER FIBROSIS IN THE INFECTION BY THE HEPATITIS B AND C VIRUS IN GUATEMALA
Abel Sanchez, Katherine Maldonado, Johana Samayoa
Ann Hepatol. 2023;28 Supl 1:100904.105
Acceso a texto completo
P-129 LIVER TRANSPLANTATION IN PATIENTS WITH HEREDITARY HEMORRHAGIC TELANGIECTASIA. EXPERIENCE OF TWO CASES AT AN ARGENTINE HHT REFERRAL CENTER
Marcelo Serra, Juan Manuel Diaz, Anibal Arias, Martín De Santibañes, Eduardo De Santibañes, Juan Carlos Bandi
Ann Hepatol. 2023;28 Supl 1:100904.106
Acceso a texto completo
P-130 CONGENITAL PORTOSYSTEMIC SHUNTS: EXPERIENCE IN A THIRD LEVEL CHILDREN`S HOSPITAL
Micaela Wisniacki, Carol Lezama Elecharri, Marcela Galoppo, Maria Solaegui, Alejandra Pedreira, Sabrina Torres, Eduardo Galli, Guillermo Eiselle, ... Elena De Mateo
Ann Hepatol. 2023;28 Supl 1:100904.107
Acceso a texto completo
O-1 ECONOMIC IMPACT OF LONG-TERM ALBUMIN INFUSIONS IN PATIENTS WITH DECOMPENSATED CIRRHOSIS AND UNCOMPLICATED ASCITES FROM THE BRAZILIAN PUBLIC AND PRIVATE HEALTHCARE SYSTEMS PERSPECTIVES
Carlos Terra, Elisabet Viayna, Laura Ayzin, Cristina Fuster, Susana Aceituno, Maria Soler, Claudio Tafla
Ann Hepatol. 2023;28 Supl 1:100904.108
Acceso a texto completo
O-2 CHARACTERIZATION OF SERUM LEVELS OF BILE ACIDS, EXTRACELLULAR VESICLES AND ITS CARGO IN ALCOHOL-ASSOCIATED LIVER DISEASE
Jorge Arnold, Luis Antonio Díaz, Francisco Idalsoaga, María Ayala Valverde, Gustavo Ayares, Paula Rivera, Nancy Solís, Fidel Allende, ... Juan Pablo Arab
Ann Hepatol. 2023;28 Supl 1:100904.109
Acceso a texto completo
O-4 CLINICAL, HISTOLOGICAL AND SEROLOGICAL FEATURES OF AUTOIMMUNE-LIKE ACUTE LIVER INJURY AFTER SARS-COV-2 VACCINATION
Marlene Padilla Lopez, Natalia Sobenko, Lucrecia Garcia Olivera, Agustina Martinez Garmendia, Eduardo Mullen, Paola Casciato, Sebastian Marciano, Alejandra Villamil
Ann Hepatol. 2023;28 Supl 1:100904.110
Acceso a texto completo
O-5 INTEGRATED ANALYSIS OF ARCHAEAL, FUNGAL AND PROTOZOAN GUT TRANSCRIPTOME IN METABOLIC ASSOCIATED FATTY LIVER DISEASE (MAFLD) IN ARGENTINA
Bárbara Suárez, María Florencia Mascardi, Flavia Noelia Mazzini, M. Ruda Vera, Sebastián Marciano, Paola Casciato, Adrián Narvaez, Leila Haddad, ... Julieta Trinks
Ann Hepatol. 2023;28 Supl 1:100904.111
Acceso a texto completo
O-6 ENHANCED METABOLISM OF AROMATIC AMINO ACIDS AND LOW-DIVERSITY GUT MICROBIOTA: SIGNATURES OF HEPATIC ENCEPHALOPATHY IN DECOMPENSATED CIRRHOTIC PATIENTS FROM WESTERN MEXICO
Tonatiuh Abimael Baltazar-Díaz, Luz Alicia González-Hernández, Juan Manuel Aldana-Ledesma, Donovan Cortina-Romero, Marcela Peña-Rodríguez, Alejandra Natali Vega-Magaña, Sara Minia Zepeda-Morales, Rocío Ivette López-Roa, ... Miriam Bueno-Topete
Ann Hepatol. 2023;28 Supl 1:100904.112
Acceso a texto completo
O-7 LIVER TOXICITY OF TYROSINE KINASE INHIBITORS: A DESCRIPTIVE ANALYSIS FROM SLATINDILI NETWORK
Nelia Hernández, Fernando Bessone, Daniela Chiodi, Norberto Tamagnone, Inmaculada Medina-Caliz, María Isabel Lucena, Raúl Andrade
Ann Hepatol. 2023;28 Supl 1:100904.113
Acceso a texto completo
O-8 CHARACTERIZATION AND EPIDEMIOLOGICAL CHANGES OF PATIENTS WITH HEPATITIS C VIRUS TREATED IN THE CHILEAN PUBLIC HEALTH SYSTEM FROM 2016 TO 2021.
Luis Salazar, Carlos Valdebenito, Alejandro Carvajal, Gonzalo Veloso, Herman Aguirre, Gabriel Mezzano
Ann Hepatol. 2023;28 Supl 1:100904.114
Acceso a texto completo
O-9 THE CHANGING EPIDEMIOLOGY OF HEPATOCELLULAR CARCINOMA IN SOUTH AMERICA: A REPORT FROM THE SOUTH AMERICAN LIVER RESEARCH NETWORK
Enrique Carrera Estupinan, Angelo Mattos, Javier Diaz Ferrer, Marina Farah, Domingo Balderramo, Estefania Liza Vaca, Marco Arrese Jimenez, Jhon Prieto Ortiz, Jose Debes
Ann Hepatol. 2023;28 Supl 1:100904.115
Acceso a texto completo
O-10 SIMILAR RISK RECLASSIFICATION OF HCC RECURRENCE BETWEEN THE AFP SCORE AND METROTICKET 2.0 AT LISTING AND AT LAST REASSESSMENT
Federico Piñero, Charlotte Costentin, Helena Degroote, Quirino Lai, Fernando Rubinstein, Christophe Duvoux
Ann Hepatol. 2023;28 Supl 1:100904.116
Acceso a texto completo
O-11 THE PUBLIC HEALTH POLICIES REDUCE THE LONG-TERM BURDEN OF ALCOHOL-ASSOCIATED LIVER DISEASE WORLDWIDE: DEVELOPMENT OF A PREPAREDNESS INDEX
Luis Antonio Díaz, Eduardo Fuentes-López, Francisco Idalsoaga, Jorge Arnold, Gustavo Ayares, Macarena Cannistra, Danae Vio, Andrea Márquez-Lomas, ... Juan Pablo Arab
Ann Hepatol. 2023;28 Supl 1:100904.117
Acceso a texto completo
O-12 CHARACTERIZATION AND UTILIZATION OF HCV-POSITIVE DONORS IN ARGENTINA
Manuel Mendizabal, Margarita Anders, Ariel Antik, Federico Piñero, Gabriela Hidalgo, Daniela Hansen Krogh, Viviana Tagliafichi, Marcelo Silva, Liliana Bisigniano
Ann Hepatol. 2023;28 Supl 1:100904.118
Acceso a texto completo
O-13 PERFORMANCE OF PRE-TRANSPLANT CRITERIA IN PREDICTION OF HEPATOCELLULAR CARCINOMA PROGRESSION AND WAITLIST DROPOUT
Federico Piñero, Marcos Thompson, Ilka Boin, Aline Chagas, Emilio Quiñonez, Carla Bermúdez, Mario Vilatobá, Luisa Santos, ... Marcelo Silva
Ann Hepatol. 2023;28 Supl 1:100904.119
Acceso a texto completo
O-14 NONALCOHOLIC FATTY LIVER DISEASE IN PATIENTS WITH CORONARY HEART DISEASE
Máximo Cattaneo, Juan Pablo Roblero, Luis Vega, Marcelo Salinas, Andrea Urra, Daniela Simian, Rosario Pino, Álvaro Urzúa, ... Jaime Poniachik
Ann Hepatol. 2023;28 Supl 1:100904.120
Acceso a texto completo
O-15 INFECTIONS BY MULTI-DRUG RESISTANT BACTERIA WERE INDEPENDENTLY ASSOCIATED WITH HOSPITAL MORTALITY IN CIRRHOTICS WITH ACUTE DECOMPENSATION: A PROSPECTIVE STUDY ON 433 ADMISSIONS
Gabriela Ruffillo, Juan Cruz Codd, Limbert Jesús Padilla Martínez, Miguel Angel Puga Tejada, Adriana Fernández Lausi, Graciela Landeira, Graciela Priore, Cristina Longo, ... Eduardo Fassio
Ann Hepatol. 2023;28 Supl 1:100904.121
Acceso a texto completo
O-16 MELD-NA AND MELD3.0 HAVE THE BEST PERFORMANCE TO PREDICT THE 28-DAY RISK OF DEATH IN PATIENTS WITH SEVERE ALCOHOLIC HEPATITIS IN THE MEXICAN POPULATION
Fátima Higuera-De La Tijera, Claudia Dorantes-Nava, Alfredo Servín-Caamaño, Francisco Salas-Gordillo, Juan Miguel Abdo-Francis, Gabriela Gutiérrez-Reyes, P Diego-Salazar, MY Carmona-Castillo, ... José Luis Pérez-Hernández
Ann Hepatol. 2023;28 Supl 1:100904.122
Acceso a texto completo
O-17 STUDY OF THE ASSOCIATION BETWEEN SERUM LEVELS OF SYSTEMIC INFLAMMATORY MARKERS AND ADVANCED FIBROSIS STAGE IN INFECTED PATIENTS WITH HEPATITIS DELTA VIRUS GENOTYPE 3
Mauricio Campos, Juan Miguel Salcedo, Deusilene Vieira, Songeli Freire, Raymundo Paraná, María Isabel Schinoni
Ann Hepatol. 2023;28 Supl 1:100904.123
Acceso a texto completo
O-18 ETHNIC DISPARITIES IN HISPANIC POPULATION WITH ALCOHOL ASSOCIATED LIVER DISEASE AND TRANSPLANT ENLISTED PATIENTS: A RETROSPECTIVE STUDY OF TWO LARGE DATABASES IN THE UNITED STATES FROM 2011-2018
Gustavo Ayares, Luis Antonio Díaz, Eduardo Fuentes-López, Francisco Idalsoaga, Jorge Arnold, Thomas Cotter, Winston Dunn, Douglas Simonetto, ... Juan Pablo Arab
Ann Hepatol. 2023;28 Supl 1:100904.124
Acceso a texto completo
O-19 COLLABORATIVE CARE TOWARDS MICROELIMINATION OF HEPATITIS C VIRUS IN A DIALYSIS POPULATION IN SOUTHERN BRAZIL
Hugo Cheinquer, Alexandre de Araujo, Dirceu da Silva Reis
Ann Hepatol. 2023;28 Supl 1:100904.125
Acceso a texto completo
O-20 MOLECULAR AND BIOLOGICAL CHARACTERIZATION OF HEPATITIS B VIRUS SUBGENOTYPE F1b CLUSTERS: UNRAVELING ITS ROLE IN HEPATOCARCINOGENESIS
María Mercedes Elizalde, Laura Mojseijczuk, Micaela Speroni, Luciana Tadey, Belén Bouzas, Lilia Mammana, Rodolfo Héctor Campos, Diego Martín Flichman
Ann Hepatol. 2023;28 Supl 1:100904.126
Acceso a texto completo
O-21 EVIDENCE OF SUBOPTIMAL PUBLIC HEALTH POLICIES ON HEPATOCELLULAR CARCINOMA IN THE AMERICAS: A HUGE DEBT OF OUR REGION
Luis Antonio Díaz, Gustavo Ayares, Francisco Idalsoaga, Jorge Arnold, Blanca Norero, Oscar Corsi, Gonzalo Pizarro, Sergio García, ... Juan Pablo Arab
Ann Hepatol. 2023;28 Supl 1:100904.127
Acceso a texto completo
O-22 DIFFERENTIAL MUTATION PATTERN ASSOCIATED WITH HEPATITIS B E ANTIGEN SEROCONVERSION BETWEEN SUBGENOTYPE F1b CLUSTERS: POTENTIAL ROLE IN PATHOGENESIS
Micaela Martínez, Mercedes Elizalde, Micaela Speroni, Rodolfo Campos, Diego Flichman
Ann Hepatol. 2023;28 Supl 1:100904.128
Acceso a texto completo
O-23 HEPATITIS B VIRUS STATUS OF ORGAN DONORS IN ARGENTINA
Maria Anders, Ariel Antik, Manuel Mendizabal, Federico Piñero, Daniela Hansen Krogh, Federico Orozco, Viviana Tagliafichi, Julia Brutti, ... Liliana Bisignano
Ann Hepatol. 2023;28 Supl 1:100904.129
Acceso a texto completo
O-24 PIRFENIDONE PREVENTS NEOPLASTIC LESIONS DEVELOPMENT BY OXIDATIVE, FIBROGENIC, ANTIPROLIFERATIVE AND EPIGENETIC MECHANISMS REGULATION IN A MODEL OF CHEMICAL HEPATOCARCINOGENESIS
Hipólito Otoniel Miranda-Roblero, Hugo Christian Monroy-Ramírez, Marina Galicia-Moreno, Ana Sandoval-Rodriguez, Arturo Santos, Juan Armendáriz-Borunda
Ann Hepatol. 2023;28 Supl 1:100904.130
Acceso a texto completo
O-25 ASSESSMENT OF MODELS FOR PREDICTING RESPONSE TO CORTICOIDS TREATMENT IN ALCOHOL-ASSOCIATED HEPATITIS: A GLOBAL COHORT STUDY
Francisco Idalsoaga, Luis Antonio Díaz, Gustavo Ayares, Jorge Arnold, Winston Dunn, Yanming Li, Ashwani Singal, Doug Simonetto, ... Juan Pablo Arab
Ann Hepatol. 2023;28 Supl 1:100904.131
Acceso a texto completo
O-26 IMMUNE PROFILING PROVIDES A SET OF 5 CYTOKINES TO DETECT HEPATOCELLULAR CARCINOMA RELATED TO VIRAL HEPATITIS IN SOUTH AMERICAN PATIENTS
Jose Debes, Enrique Carrera Estupinan, Melina Rocio Ferreiro, Angelo Mattos, Domingo Balderramo, Maria Massotti, Joe Koopmeiners, Andre Boonstra
Ann Hepatol. 2023;28 Supl 1:100904.132
Acceso a texto completo
O-30 ALCOHOL-HARM PARADOX IN LATIN AMERICA: HOW TO STUDY IT DESPITE DATA LIMITATIONS? THE CHILEAN EXPERIENCE
Juan Pablo Roblero, Juan Pablo Arab, Jaime Poniachik, Ramon Bataller, Luis Antonio Díaz
Ann Hepatol. 2023;28 Supl 1:100904.133
Acceso a texto completo
O-31 DIAGNOSTIC PERFORMANCE OF BAVENO VII CRITERIA FOR EXCLUSION OF ESOPHAGEAL VARICES: A RETROSPECTIVE STUDY
Williams Celedonio Campos, Celide Campoverde-Cueva, Brayan Campos, Rommel Zambrano-Huailla, Alejandra Zevallos, Jorge Garavito-Renteria
Ann Hepatol. 2023;28 Supl 1:100904.134
Acceso a texto completo
O-32 FULMINANT AUTOIMMUNE HEPATITIS: CLINICAL PRESENTATION, OUTCOME AND PROGNOSTIC FACTORS.
Alejandra Villamil, Marlene Padilla, Eduardo Mullen, Juan Carlos Bandi, Gabriel Carballo, Natalia Sobenko, Sebastian Marciano
Ann Hepatol. 2023;28 Supl 1:100904.135
Acceso a texto completo
O-33 PREVALENCE OF HIGH-RISK NON-ALCOHOLIC STEATOHEPATITIS ACCORDING TO THE FAST® INDEX IN A GROUP OF DIABETIC PATIENTS
Andrés Burak-Leipuner, Fatima Higuera-de la Tijera, Alfredo Servín-Caamaño, Javier Romero-Bermúdez, Laura Ceceña-Martínez, Felix García-Gorrosquieta, Kevin Vázquez-Hernández, Nidia Uribe-Rivera, ... José Luis Pérez-Hernández
Ann Hepatol. 2023;28 Supl 1:100904.136
Acceso a texto completo
O-34 PATIENT AND GRAFT SURVIVAL IN RECIPIENTS OF DE NOVO SIMULTANEOUS LIVER-KIDNEY TRANSPLANTATION
Agustina Martínez Garmendia, Marlene Padilla, Tomas Fescina, María Cora Giordani, Gustavo Greloni, Rosana Groppa, Nora Imperialii, Paola Casciato, Sebastián Marciano
Ann Hepatol. 2023;28 Supl 1:100904.137
Acceso a texto completo
O-35 EPIDEMIOLOGY, CLINICAL AND TISSUE CHARACTERISTICS OF A LARGE COHORT OF NAFLD/NASH FROM SOUTH AMERICA
Jhon Prieto Ortiz, Joseph Akambase, Angelo Mattos, Enrique Carrera Estupinan, Javier Diaz Ferrer, Andre Curia, Patricia Gallardo, Esteban Gonzalez Ballerga, ... Jose Debes
Ann Hepatol. 2023;28 Supl 1:100904.138
Acceso a texto completo
O-36 UTILITY OF DRIED BLOOD SAMPLES FOR HEPATITIS C VIRUS GENOTYPING AMONG HCV/HIV-COINFECTED INDIVIDUALS
Geane Lopes Flores, Barbara Vieira Do Lago, Amanda Rodrigues Caetano, Vanessa Alves Marques, Daniela Rodrigues Pontes Pires, Carlos Eduardo Brandão-Mello, Cristiane Villela-Nogueira, Lia-Laura Lewis Ximenes, AndLivia Melo Villar
Ann Hepatol. 2023;28 Supl 1:100904.139
Acceso a texto completo
O-37 AMOXICILLIN-CLAVULANATE INDUCED LIVER INJURY: TEN YEARS EXPERIENCE FROM LATINDILI REGISTRY.
Nelia Hernandez, Fernando Bessone, Daniela Chiodi, Manuel Mendizabal, A Sanchez, Ezequiel Ridruejo, Carla Bianchi, Carmen Pollio, ... María Isabel Lucena
Ann Hepatol. 2023;28 Supl 1:100904.140
Acceso a texto completo
O-38 FULMINANT WILSON: A WELL-DEFINED ENTITY. HOW TO DIAGNOSE IT QUICKLY TO PREVENT MORTALITY
Francisco Hevia, Mónica Penón, Stephanie Lotz, Alfredo Mora, Gabriela Jiménez, Ramsés Badilla, Mildred Jiménez, Manuel Saborío, ... Danny Alvarado
Ann Hepatol. 2023;28 Supl 1:100904.141
Acceso a texto completo
O-39 CLINICAL CHARACTERISTICS AND OUTCOME OF DRUG-INDUCED LIVER INJURY DUE TO ANTINEOPLASTIC AND BIOLOGICAL AGENTS
Fernando Bessone, Nelia Hernandez, Raymundo Parana, Maria Isabel Schinoni, Manuel Mendizabal, Adriana Sanchez, Vinicius Nunes, Ezequiel Ridruejo, ... Raul J Andrade
Ann Hepatol. 2023;28 Supl 1:100904.142
Acceso a texto completo
O-40 PROGNOSTIC ROLE OF MAGNETIC RESONANCE OF THE ABDOMEN WITH INTRAVENOUS CONTRAST AND CHOLANGIORESONANCE IN PRIMARY SCLEROSING CHOLANGITIS: OUR EXPERIENCE
Roy López Grove, Florencia Vespa, Martina Aineseder, Alejandra Villamil, Juan Carlos Spina
Ann Hepatol. 2023;28 Supl 1:100904.143
Acceso a texto completo
O-41 CIRRHOSIS IN PATIENTS WITH ALFA 1 ANTITRYPSIN DEFICIENCY; WHAT ARE WE MISSING?
Francisco Hevia, Daniela Hernández, Alfredo Mora, Ramsés Badilla, Natassia Camacho, Mildred Jiménez, Manuel Saborío, Karina Hidalgo, ... Danny Alvarado
Ann Hepatol. 2023;28 Supl 1:100904.144
Acceso a texto completo
O-42 COSTA RICA NATIONAL NEWBORN SCREENING LABORATORY´S EXPERIENCE IN DIAGNOSING ALPHA-1 ANTITRYPSIN DEFICIENCY
Mariela Solano-Vargas, Juan Diego Gutiérrez-Ávila, Jessica Arroyo-Hernández, Danny Alvarado-Romero, Natassia Camacho-Matamoros, Mildred Jiménez-Hernández
Ann Hepatol. 2023;28 Supl 1:100904.145
Acceso a texto completo
O-43 RISK FACTORS FOR CANCER DEVELOPMENT IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS
Michelle Harriz Braga, Guilherme Grossi Lopes Cançado, Paulo Lisboa Bittencourt, Cláudia Alves Couto, Laura Vilar Guedes, André Mourão Costa Lima, Maria Lucia Gomes Ferraz, Cristiane Alves Villela-Nogueira, ... Eduardo Luiz Rachid Cançado
Ann Hepatol. 2023;28 Supl 1:100904.146
Acceso a texto completo
OP-2 PREVALENCE OF NON-ALCOHOLIC FATTY LIVER DISEASE AND ITS ASSOCIATION WITH PHYSICAL ACTIVITY LEVELS AMONG ADULTS IN CHILE
Paulina Pettinelli, Tiziana Fernández, Carolina Aguirre, Francisco Barrera, Arnoldo Riquelme, Rodrigo Fernández-Verdejo
Ann Hepatol. 2023;28 Supl 1:100904.147
Acceso a texto completo
OP-3 CLINICAL PRESENTATION AND CAUSATIVE AGENTS OF IDIOSYNCRATIC DRUG-INDUCED LIVER INJURY IN URUGUAY: FIRST DECADE OF EXPERIENCE.
Nelia Hernandez, Daniela Chiodi, Adriana Sanchez, Laura Reyes, Ximena Pazos, María di Pace, Carla Bianchi, Yessica Pontet, ... María Isabel Lucena
Ann Hepatol. 2023;28 Supl 1:100904.148
Acceso a texto completo
OP-4 IMPLEMENTATION OF A RE-LINKAGE TO CARE STRATEGY IN PATIENTS WITH CHRONIC HEPATITIS C WHO WERE LOST TO FOLLOW-UP IN LATIN AMERICA
Manuel Mendizabal, Marcos Thompson, Esteban Gonzalez-Ballerga, Margarita Anders, Graciela E Castro-Narro, Mario G Pessoa, Hugo Cheinquer, Gabriel Mezzano, ... Marcelo O Silva
Ann Hepatol. 2023;28 Supl 1:100904.149
Acceso a texto completo
OP-5 ALCOHOL-ASSOCIATED HEPATITIS IN LATIN AMERICA: RESULTS FROM THE AH-LATIN STUDY
Luis Antonio Díaz, Jorge Arnold, Francisco Idalsoaga, Gustavo Ayares, María Ayala-Valverde, Diego Perez, Jaime Gomez, Rodrigo Escarate, ... Juan Pablo Arab
Ann Hepatol. 2023;28 Supl 1:100904.150
Acceso a texto completo
Publique en
Annals of Hepatology
Affiliated societies
